Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Learn how to use credit card points for maximum benefit. Discover strategies to redeem your points wisely and enhance your rewards.
24,819 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Tired of picking individual stocks? Discover how to build a complete portfolio with 3 ETFs that cover global equities...
Two AI stocks carry consensus upside targets of 47% and 54%. This guide explains what drives those bets and how to ev...
Nike delivered a quarterly beat that sent its shares higher, but investors kept a close eye on tariffs and future gui...
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A sudden geopolitical flare pushes crypto and traditional markets lower. This morning minute: markets tumble, testing...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
Astera Labs sits at a pivotal point in the data center supply chain. This article breaks down why the stock could ris...
In a market hungry for outsized gains, the idea of a spectacular growth stock before it erupts can be tempting. This ...